跳至主要内容
临床试验/EUCTR2012-004856-12-AT
EUCTR2012-004856-12-AT进行中(未招募)1 期

Changes of cytokines and regulatory T cells in renal transplant recipients after switch to the mTOR inhibitor Everolimus. A Single center trial, non-blinded, non-randomized. - Immunological changes due to mTORi

Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klinische Abteilung für Nephrologie0 个研究点目标入组 40 人开始时间: 2013年2月12日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Kidney transplant recipients
  • First kidney transplantation
  • Aged between 18-70 years
  • At risk for CMV infection (donor CMV IgG positive)
  • Written informed consent before entry into the study
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 35
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 5

排除标准

  • Re-transplantation
  • Living Donor Transplantation
  • Known intolerance to substance (everolimus)
  • Participation in any other study

研究者

发起方
Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klinische Abteilung für Nephrologie

相似试验